bupropion
- Product NDC
- 50090-3854
- 11-digit product format
- 500903854
- Labeler code
- 50090
- Product ID
- 50090-3854_49d07ec8-c046-408e-ae3a-12235dfe1545
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bupropion hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA202304
- Marketing category
- ANDA
- Marketing start
- 2014-11-01
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-3854-0 | 50090385400 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-3854-0) | 2018-11-21 | 0000-00-00 | No | No | Current |
| 50090-3854-1 | 50090385401 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50090-3854-1) | 2014-11-28 | 0000-00-00 | No | No | Current |
| 50090-3854-2 | 50090385402 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50090-3854-2) | 2014-11-28 | 0000-00-00 | No | No | Current |
| 50090-3854-3 | 50090385403 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50090-3854-3) | 2014-11-28 | 0000-00-00 | No | No | Current |